New brain cancer drug enters first human safety tests
Disease control
Completed
This was a small, early-stage study to test the safety and dosing of a new drug called tinostamustine for a type of brain cancer called glioblastoma. It involved 10 adults who had recently finished standard radiation and chemotherapy. The main goal was to find the highest dose pa…
Phase: EARLY_PHASE1 • Sponsor: Mundipharma Research Limited • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC